You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

ROXANE Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for ROXANE, and what generic and branded alternatives to ROXANE drugs are available?

ROXANE has one hundred and twenty-eight approved drugs.

There are ten tentative approvals on ROXANE drugs.

Drugs and US Patents for ROXANE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roxane LAMOTRIGINE lamotrigine TABLET;ORAL 077392-004 Jan 27, 2009 DISCN No No ⤷  Sign Up ⤷  Sign Up
Roxane NAPROXEN naproxen TABLET;ORAL 074211-003 Feb 28, 1994 DISCN No No ⤷  Sign Up ⤷  Sign Up
Roxane MIRTAZAPINE mirtazapine TABLET;ORAL 076270-002 Jun 19, 2003 DISCN No No ⤷  Sign Up ⤷  Sign Up
Roxane METHOCARBAMOL methocarbamol TABLET;ORAL 088647-001 Feb 29, 1984 DISCN No No ⤷  Sign Up ⤷  Sign Up
Roxane PREDNISONE prednisone TABLET;ORAL 087833-001 May 4, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up
Roxane NAPROXEN SODIUM naproxen sodium TABLET;ORAL 074257-001 Dec 21, 1993 DISCN No No ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.